Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140595
Status:
COMPLETED
Last Update Posted:
2011-03-04
First Post:
2005-08-31
Brief Title:
ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1
Sponsor:
Lymphoma Study Association
Organization:
Lymphoma Study Association
Organization Data
Organization:
Lymphoma Study Association
Class:
OTHER
Study ID:
LNH03-2B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lymphoma Study Association
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Amgen | INDUSTRY |